JAK2 and cyclic hematopoiesis: Association of JAK2 mutations with CH was first reported in 2005 when these mutations were detected in a vast majority of individuals with polycythemia vera (PV) [61,62], a myeloproliferative disorder characterized by overproduction of erythrocytes and thrombocytes.